Related Experiment Video
Updated: Jun 23, 2026
07:30
Rapid Nanoprobe Signal Enhancement by In Situ Gold Nanoparticle Synthesis
Published on: March 7, 2018
Amplified immune response by ginsenoside-based nanoparticles (ginsomes)
Xiaoming Song1, Liming Zang, Songhua Hu
1Department of Veterinary Medicine, College of Animal Sciences, Zhejiang University, 268 Kaixuan Rd, Hangzhou, Zhejiang 310029, PR China.
Vaccine
|May 12, 2009
Summary
Novel ginsenoside-based nanoparticles (ginsomes) significantly boost immune responses in mice. These nanoparticles enhance antibody production and lymphocyte proliferation, indicating potential as a powerful new adjuvant.
Area of Science:
- Immunology
- Nanotechnology
- Pharmacology
Background:
- Adjuvants are crucial for enhancing vaccine efficacy.
- Ginsenosides, derived from Panax ginseng, possess immunomodulatory properties.
- Nanoparticle formulations offer improved drug delivery and immune stimulation.
Purpose of the Study:
- To develop and characterize ginsenoside-based nanoparticles (ginsomes) as a novel adjuvant.
- To evaluate the immunomodulatory activity of ginsomes in vivo.
- To assess the impact of ginsomes on humoral and cellular immune responses.
Main Methods:
- Ginsomes were formulated using ginseng saponins, cholesterol, and phosphatidyl choline via dialysis.
- Nanoparticle characterization included size and morphology analysis.
- Immunological assays in mice involved co-administration with ovalbumin (OVA) to measure IgG responses, lymphocyte proliferation, and cytokine production (IFN-gamma, IL-5).
Main Results:
- Ginsomes were spherical nanoparticles (70-107nm) containing specific ginsenosides.
- Co-administration of ginsomes with OVA significantly increased total IgG levels and IgG subclass responses (IgG1, IgG2a, IgG2b, IgG3) compared to OVA alone.
- Ginsomes enhanced T and B lymphocyte proliferation and promoted balanced Th1/Th2 cytokine production (IFN-gamma and IL-5).
Conclusions:
- Ginsomes represent a novel and effective adjuvant for enhancing both humoral and cellular immunity.
- The study demonstrates the potential of ginsomes to up-regulate Th1 and Th2 immune responses.
- Ginsomes show promise for development as immunomodulatory agents in vaccines or therapeutics.
